These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37494665)

  • 1. Sirt3 regulates NLRP3 and participates in the effects of plantainoside D on acute lung injury sepsis.
    Wang J; Li W; Zhao F; Han Q; Shan L; Qian Y
    Aging (Albany NY); 2023 Apr; 15(14):6710-6720. PubMed ID: 37494665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome.
    Li J; Bai Y; Tang Y; Wang X; Cavagnaro MJ; Li L; Li Z; Zhang Y; Shi J
    Front Immunol; 2022; 13():812164. PubMed ID: 35222388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT3 alleviates sepsis-induced acute lung injury by inhibiting pyroptosis via regulating the deacetylation of FoxO3a.
    Wu Z; Wang Y; Lu S; Yin L; Dai L
    Pulm Pharmacol Ther; 2023 Oct; 82():102244. PubMed ID: 37499855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic helix B peptide alleviates sepsis-induced acute lung injury by downregulating NLRP3 inflammasome activation in alveolar macrophages.
    Zhang XP; Zhang WT; Qiu Y; Ju MJ; Yang C; Tu GW; Luo Z
    Int Immunopharmacol; 2020 Nov; 88():106849. PubMed ID: 32795894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM3 is associated with acute lung injury in septic mice and patients via the NF-κB/NLRP3 pathway.
    Long F; Hu L; Chen Y; Duan X; Xie K; Feng J; Wang M
    Inflamm Res; 2023 Apr; 72(4):731-744. PubMed ID: 36781430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Limb Bud and Heart Alleviates Sepsis-Induced Acute Lung Injury via Inhibiting the NLRP3 Inflammasome.
    Wang Y; Shi Y; Zhang X; Fu J; Chen F
    Biomed Res Int; 2021; 2021():4084371. PubMed ID: 33553423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Gingerol attenuates sepsis-induced acute lung injury by suppressing NLRP3 inflammasome through Nrf2 activation.
    Pan Q; Liu P; Wan M
    Folia Histochem Cytobiol; 2023; 61(1):68-80. PubMed ID: 36734635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
    Li J; Ma J; Li M; Tao J; Chen J; Yao C; Yao S
    Life Sci; 2021 Apr; 271():119192. PubMed ID: 33577850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRPK1 promotes sepsis-induced acute lung injury via regulating PI3K/AKT/FOXO3 signaling.
    Guo W; Hu Z
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):203-212. PubMed ID: 36226860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury.
    Jiang T; Liu E; Li Z; Yan C; Zhang X; Guan J; Zhan Y; Zhao B; Ding W
    Int J Surg; 2024 May; 110(5):2649-2668. PubMed ID: 38445453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2.
    Ning L; Rui X; Guorui L; Tinglv F; Donghang L; Chenzhen X; Xiaojing W; Qing G
    Cell Mol Life Sci; 2022 Nov; 79(12):610. PubMed ID: 36449070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice.
    Hu H; Jiang H; Zhang K; Zhang Z; Wang Y; Yi P; Zhang G; Sun Y
    Biomed Pharmacother; 2022 Dec; 156():113804. PubMed ID: 36272262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
    Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
    Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
    Liao H; Zhang S; Qiao J
    Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury.
    Li R; Zhao Y; Zhang X; Yang L; Zou X
    Immunol Invest; 2023 Nov; 52(5):567-582. PubMed ID: 37139806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of STAT6 enhances murine acute lung injury through NLRP3/p38 MAPK signaling pathway in macrophages.
    Hu L; Shao C; Pan L; Jiang Z
    BMC Immunol; 2022 May; 23(1):25. PubMed ID: 35606692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt3 Maintains Microvascular Endothelial Adherens Junction Integrity to Alleviate Sepsis-Induced Lung Inflammation by Modulating the Interaction of VE-Cadherin and
    Chen DQ; Shen MJ; Wang H; Li Y; Tang AL; Li S; Xiong MC; Guo Y; Zhang GQ
    Oxid Med Cell Longev; 2021; 2021():8978795. PubMed ID: 34630854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway.
    He G; Chen K; Wang H; Li X; Li W; Liu L; Chen J; Yang D; Hu J; Xu D; Wen F; Wang T
    Eur J Pharmacol; 2022 Jul; 926():175047. PubMed ID: 35609679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of iPSC-derived conditioned medium with ceftriaxone alleviates bacteria-induced lung injury by targeting the NLRP3 inflammasome.
    Wann SR; Chi PL; Huang WC; Cheng CC; Chang YT
    J Cell Physiol; 2022 Feb; 237(2):1299-1314. PubMed ID: 34612516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury.
    Liu Y; Yang H; Zhu F; Ouyang Y; Pan P
    Inflammopharmacology; 2023 Aug; 31(4):2007-2021. PubMed ID: 37115345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.